Jan 7, 2026 12:44AM
Dec 15, 2025 04:39PM
Nov 13, 2025 04:05PM
Aug 13, 2025 04:00PM
May 14, 2025 04:15PM
Mar 27, 2025 04:01PM
Mar 10, 2025 04:39PM Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy
Nov 14, 2024 04:01PM
Aug 14, 2024 04:01PM
May 15, 2024 04:01PM
Mar 28, 2024 06:30AM
Dec 11, 2023 06:26AM
Nov 14, 2023 04:01PM
Nov 6, 2023 05:00AM Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulator
Mar 28, 2023 04:08PM
Feb 9, 2023 07:30AM
Aug 9, 2022 04:33PM
Aug 8, 2022 06:30AM
Aug 8, 2022 06:30AM
May 19, 2022 08:00AM
Feb 3, 2022 05:33AM Kodiak Sciences Inc. (KOD) Completes Enrollment in GLEAM and GLIMMER Phase 3 Trials
Feb 3, 2022 05:30AM
Dec 16, 2021 05:30AM
Sep 1, 2021 05:45AM
Dec 3, 2020 11:00AM
Nov 16, 2020 06:53AM
Nov 16, 2020 06:53AM
Nov 11, 2020 11:27PM Kodiak Sciences Announces Presentation of KSI-301 Phase 1b Clinical Study Data Focused on Diabetic Macular Edema at American Academy of Ophthalmology (AAO) 2020 Virtual Meeting
Nov 9, 2020 05:30AM
Aug 10, 2020 05:30AM
Jul 16, 2020 04:38PM
Jul 10, 2020 04:02PM
Jul 10, 2020 04:00PM
May 11, 2020 05:30AM
Mar 16, 2020 05:30AM Kodiak Sciences Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
Mar 3, 2020 04:49AM
Dec 3, 2019 09:16AM
Nov 12, 2019 05:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All